Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study

Jaclyn Tamaroff, MD, MSCI, and Jonathan Soslow, MD, MSCI, are co-leading a study evaluating the safety and tolerability of glucagon-like peptide-1 (GLP-1) receptor agonist drugs in patients with…

Read More

Registration now open for Diabetes Day 2026

Diabetes Day 2026 will take place at Vanderbilt on Tuesday, Nov. 10. Registration is open now until Nov. 2, 2026. Plenary speakers include Mohammed Ali, MD, Co-Director, Emory Global Diabetes…

Read More

Human islet function, diabetes risk defined by heterogeneous endocrine cell composition

Multisite consortium analyzed human pancreatic islet cells from nondiabetic organ donors in innovative method to better understand pathophysiology of diabetes. DRTC member Marcela Brissova, PhD,…

Read More

Multi-organ metabolite ‘signature’ signals increased heart failure risk

A multi-institutional group, including DRTC members, has identified a “signature” of metabolic molecules associated with exercise-induced physiologic deficits that, when released into the…

Read More

Local group raises $2,500 for diabetes advocacy and research at ADA Step Out Walk

The Vanderbilt Diabetes Research and Training Center (DRTC) team participated in the 2026 ADA Step Out Walk on Saturday, May 2 in Nashville. The VDRC raised over $2,500 in donations that will go…

Read More